Laura Arribillaga

973 total citations
22 papers, 819 citations indexed

About

Laura Arribillaga is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Laura Arribillaga has authored 22 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Laura Arribillaga's work include Immunotherapy and Immune Responses (13 papers), Hepatitis C virus research (9 papers) and Immune Response and Inflammation (7 papers). Laura Arribillaga is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Hepatitis C virus research (9 papers) and Immune Response and Inflammation (7 papers). Laura Arribillaga collaborates with scholars based in Spain, France and United Kingdom. Laura Arribillaga's co-authors include Juan José Lasarte, Pablo Sarobe, Francisco Borrás‐Cuesta, Jesús Prìeto, Noëlia Casares, Ignacio Melero, Javier Dotor, José Ignacio Riezu‐Boj, Marta Gorraiz and Ascensión López-Dı́az de Cerio and has published in prestigious journals such as The Journal of Immunology, Hepatology and Journal of Virology.

In The Last Decade

Laura Arribillaga

22 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Arribillaga Spain	14	516	204	188	175	163	22	819
Tobias Warger Germany	12	722 1.4×	245 1.2×	356 1.9×	134 0.8×	244 1.5×	21	1.2k
Xuezhi Cao China	11	676 1.3×	122 0.6×	175 0.9×	243 1.4×	311 1.9×	16	929
Tinghua Cao United States	15	610 1.2×	121 0.6×	239 1.3×	130 0.7×	213 1.3×	21	913
Carine Brinster France	11	447 0.9×	169 0.8×	177 0.9×	76 0.4×	120 0.7×	22	719
Barbara Aufiero United States	12	336 0.7×	71 0.3×	218 1.2×	187 1.1×	399 2.4×	13	1.0k
Alaap B. Shah United States	12	604 1.2×	106 0.5×	126 0.7×	169 1.0×	99 0.6×	13	781
Yinghui Shi China	10	200 0.4×	120 0.6×	151 0.8×	58 0.3×	180 1.1×	19	625
Danièle Monneron France	6	850 1.6×	126 0.6×	190 1.0×	294 1.7×	160 1.0×	6	1.1k
Kozo Yokomuro Japan	14	663 1.3×	119 0.6×	119 0.6×	155 0.9×	185 1.1×	56	971
Sylvie Beaulieu Canada	9	801 1.6×	81 0.4×	122 0.6×	223 1.3×	373 2.3×	13	1.2k

Countries citing papers authored by Laura Arribillaga

Since Specialization

Citations

This map shows the geographic impact of Laura Arribillaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Arribillaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Arribillaga more than expected).

Fields of papers citing papers by Laura Arribillaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Arribillaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Arribillaga. The network helps show where Laura Arribillaga may publish in the future.

Co-authorship network of co-authors of Laura Arribillaga

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Arribillaga. A scholar is included among the top collaborators of Laura Arribillaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Arribillaga. Laura Arribillaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arribillaga, Laura, Timothy S. Gomez, Teresa Lozano, et al.. (2020). Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens. Journal for ImmunoTherapy of Cancer. 8(1). e000704–e000704. 15 indexed citations

Rollier, Christine S., Ernst J. Verschoor, Babs E. Verstrepen, et al.. (2016). T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates. Gene Therapy. 23(10). 753–759. 8 indexed citations

Arribillaga, Laura, Teresa Lozano, Francesc Rudilla, et al.. (2013). A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell ResponsesIn Vivo. BioMed Research International. 2013. 1–9. 15 indexed citations

Román, Beatriz San, Victoria Garrido, Pilar M. Muñoz, et al.. (2012). The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice. Veterinary Research. 43(1). 31–31. 4 indexed citations

Román, Beatriz San, X. de Andrés, Pilar M. Muñoz, et al.. (2012). The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model. Vaccine. 30(15). 2564–2569. 10 indexed citations

Rudilla, Francesc, Catherine Fayolle, Noëlia Casares, et al.. (2012). Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses. Vaccine. 30(18). 2848–2858. 22 indexed citations

Mansilla, Cristina, Pedro Berraondo, Marta Martínez, et al.. (2011). Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin. International Journal of Cancer. 131(3). 641–651. 43 indexed citations

Arribillaga, Laura, Javier Dotor, José Ignacio Riezu‐Boj, et al.. (2010). Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis. Cytokine. 53(3). 327–333. 63 indexed citations

Casares, Noëlia, Francesc Rudilla, Laura Arribillaga, et al.. (2010). A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice. The Journal of Immunology. 185(9). 5150–5159. 100 indexed citations

10.

Mansilla, Cristina, Marta Gorraiz, Marta Martínez‐Avilés, et al.. (2009). Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein. Journal of Hepatology. 51(3). 520–527. 21 indexed citations

11.

Lasarte, Juan José, Noëlia Casares, Marta Gorraiz, et al.. (2007). The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo. The Journal of Immunology. 178(2). 748–756. 85 indexed citations

12.

Zabaleta, Aintzane, Laura Arribillaga, Diana Llópiz, et al.. (2007). Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Antiviral Research. 74(1). 25–35. 12 indexed citations

13.

Zabaleta, Aintzane, Diana Llópiz, Laura Arribillaga, et al.. (2007). Vaccination Against Hepatitis C Virus With Dendritic Cells Transduced With an Adenovirus Encoding NS3 Protein. Molecular Therapy. 16(1). 210–217. 29 indexed citations

14.

Alfaro, Carlos, Oihana Murillo, Iñigo Tirapu, et al.. (2006). El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas. Anales del Sistema Sanitario de Navarra. 29(1). 77–96. 4 indexed citations

15.

Arribillaga, Laura, Pablo Sarobe, Ainhoa Arina, et al.. (2005). Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine. 23(27). 3493–3499. 34 indexed citations

16.

Arribillaga, Laura, Pablo Sarobe, Marta Gorraiz, et al.. (2004). 387 Protection against infection with an HCV-recombinant vaccinia virus by vaccination with an adenoviral vector enconding hepatitis C virus (HCV) NS4A protein. Journal of Hepatology. 40. 115–116. 1 indexed citations

17.

Sarobe, Pablo, Juan José Lasarte, Aintzane Zabaleta, et al.. (2003). Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses. Journal of Virology. 77(20). 10862–10871. 118 indexed citations

18.

Casares, Noëlia, Laura Arribillaga, Pablo Sarobe, et al.. (2003). CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination. The Journal of Immunology. 171(11). 5931–5939. 158 indexed citations

19.

Lasarte, Juan José, Pablo Sarobe, Patricia Boya, et al.. (2003). A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage. Hepatology. 37(2). 461–470. 19 indexed citations

20.

Arribillaga, Laura, Pablo Sarobe, Noëlia Casares, et al.. (2002). Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine. 21(3-4). 202–210. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact